000			01922 a2200505 4500
005			20250514042718.0
264		0	_c20030507
008			200305s 0 0 eng d
022			_a0171-967X
024	7		_a10.1007/s00223-001-1138-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aShui, C
245	0	0	_aThe immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand. _h[electronic resource]
260			_bCalcified tissue international _cNov 2002
300			_a437-46 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAcid Phosphatase _xgenetics
650	0	4	_aAnimals
650	0	4	_aCarrier Proteins _xpharmacology
650	0	4	_aCell Differentiation _xdrug effects
650	0	4	_aCell Division
650	0	4	_aCell Line
650	0	4	_aCyclosporine _xpharmacology
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Combinations
650	0	4	_aDrug Synergism
650	0	4	_aImmunosuppressive Agents _xpharmacology
650	0	4	_aIsoenzymes _xgenetics
650	0	4	_aMembrane Glycoproteins _xpharmacology
650	0	4	_aMice
650	0	4	_aMonocytes _xdrug effects
650	0	4	_aOsteoclasts _xdrug effects
650	0	4	_aRANK Ligand
650	0	4	_aRNA, Messenger _xmetabolism
650	0	4	_aReceptor Activator of Nuclear Factor-kappa B
650	0	4	_aReceptors, Calcitonin _xgenetics
650	0	4	_aSirolimus _xpharmacology
650	0	4	_aTacrolimus _xpharmacology
650	0	4	_aTartrate-Resistant Acid Phosphatase
650	0	4	_aTransforming Growth Factor beta _xpharmacology
700	1		_aRiggs, B L
700	1		_aKhosla, S
773	0		_tCalcified tissue international _gvol. 71 _gno. 5 _gp. 437-46
856	4	0	_uhttps://doi.org/10.1007/s00223-001-1138-3 _zAvailable from publisher's website
999			_c12084232 _d12084232